Anlon Healthcare Ltd vs Shankar Lal Rampal Dye Chem Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 30, 2026

Key Highlights

The Latest Trading Price of Anlon Healthcare Ltd is ₹ 111.3 as of 30 Mar 15:30 . The P/E Ratio of Anlon Healthcare Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Shankar Lal Rampal Dye-Chem Ltd changed from 5.9 on March 2021 to 31 on March 2025 . This represents a CAGR of 39.35% over 5 years The Market Cap of Anlon Healthcare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Shankar Lal Rampal Dye-Chem Ltd changed from ₹ 44.83 crore on March 2021 to ₹ 353.1 crore on March 2025 . This represents a CAGR of 51.10% over 5 years The revenue of Anlon Healthcare Ltd for the Dec '25 is ₹ 35.78 crore as compare to the Sep '25 revenue of ₹ 52.23 crore. This represent the decline of -31.5% The revenue of Shankar Lal Rampal Dye-Chem Ltd for the Dec '25 is ₹ 90.54 crore as compare to the Sep '25 revenue of ₹ 112.72 crore. This represent the decline of -19.68% The ebitda of Anlon Healthcare Ltd for the Dec '25 is ₹ 12.54 crore as compare to the Sep '25 ebitda of ₹ 13.77 crore. This represent the decline of -8.93% The ebitda of Shankar Lal Rampal Dye-Chem Ltd for the Dec '25 is ₹ 2.67 crore as compare to the Sep '25 ebitda of ₹ 3.81 crore. This represent the decline of -29.92% The net profit of Anlon Healthcare Ltd changed from ₹ 4.54 crore to ₹ 5.15 crore over 7 quarters. This represents a CAGR of 7.47% The net profit of Shankar Lal Rampal Dye-Chem Ltd changed from ₹ 3.48 crore to ₹ 2.08 crore over 7 quarters. This represents a CAGR of -25.48% The Dividend Payout of Anlon Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Shankar Lal Rampal Dye-Chem Ltd changed from 1.4 % on March 2021 to 2.81 % on March 2025 . This represents a CAGR of 14.95% over 5 years .

About Anlon Healthcare Ltd

Anlon Healthcare Limited was originally incorporated as 'Anlon Ventures Private Limited', dated November 19, 2013 issued by the RoC. The Company changed the name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh Certificate of Incorporation dated May 27, 2015 was issued by the RoC. The status of the Company was subsequently converted to a Public Limited and the name of the Company was changed to 'Anlon Healthcare Limited' dated September 2, 2024 by the RoC. Anlon Healthcare is engaged in manufacturing of Pharma Intermediates and APIs.
They are one of the few manufacturers of loxoprofen sodium dihydrate in India, a notable API , widely used in treatment of pain/inflammation association with conditions including rheumatoid arthritis, osteoarthritis, lower back pain, frozen shoulder, neck-shoulder-arm syndrome, tooth pain or after surgery, injury or tooth extraction.

About Shankar Lal Rampal Dye-Chem Ltd

Shankar Lal Rampal Dye-Chem Limited was originally constituted as a Private Limited Company in the name and styles of 'M/s.
Shankar Lal Rampal Dye-Chem Private Limited' vide an Incorporation Certificate on September 19, 2005.
Subsequently, it was converted into a Public Limited Company and the name of the Company was changed to 'Shankar Lal Rampal Dye-Chem Limited' vide a fresh Certificate of Incorporation dated May 08, 2018 issued by Registrar of Companies, Jaipur. The Company has made a prominent mark for itself in the Chemical industry, since its incorporation in 2005.
The Company's business in the trading of Dyes and Chemicals was started by Late Shree Shankar Lal Inani in 2005.
Based in Bhilwara (Rajasthan), the Company is named as a prominent Trader, Exporter, Importer, and Supplier of Sodium Sulphide flakes Red and Yellow, Soduim Hydro Sulphite , Hydrogen Peroxide, Citric Acid Monohydrate / Anhydrous, Phosphate Chemicals-sodium Hexameta phosphate, Sodium Tripoly phosphate, Tri Sodium Phosphate, Sodium Nitrite, and Refined Glycerine in India.

FAQs for the comparison of Anlon Healthcare Ltd and Shankar Lal Rampal Dye-Chem Ltd

Which company has a larger market capitalization, Anlon Healthcare Ltd or Shankar Lal Rampal Dye-Chem Ltd?

Market cap of Anlon Healthcare Ltd is 616 Cr while Market cap of Shankar Lal Rampal Dye-Chem Ltd is 268 Cr

What are the key factors driving the stock performance of Anlon Healthcare Ltd and Shankar Lal Rampal Dye-Chem Ltd?

The stock performance of Anlon Healthcare Ltd and Shankar Lal Rampal Dye-Chem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anlon Healthcare Ltd and Shankar Lal Rampal Dye-Chem Ltd?

As of March 30, 2026, the Anlon Healthcare Ltd stock price is INR ₹116.0. On the other hand, Shankar Lal Rampal Dye-Chem Ltd stock price is INR ₹41.99.

How do dividend payouts of Anlon Healthcare Ltd and Shankar Lal Rampal Dye-Chem Ltd compare?

To compare the dividend payouts of Anlon Healthcare Ltd and Shankar Lal Rampal Dye-Chem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.